In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 946426-89-7, name is 5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-methanol, introducing its new discovery. 946426-89-7
COMPOUNDS USEFUL IN MODULATING THE FARNESOID X RECEPTOR AND METHODS OF MAKING AND USING THE SAME
Provided are compounds that can act as a modulator of a farnesoid X receptor (FXR) and that can be useful in the treatment of diseases and/or disorders associated with the FXR. Compositions including such compounds are also provided along with methods for preparing compounds of the present invention and their use.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.946426-89-7, you can also check out more blogs about946426-89-7
Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem